Skip to content

Advertisement

  • Research
  • Open Access

Canine caliciviruses of four serotypes from military and research dogs recovered in 1963−1978 belong to two phylogenetic clades in the Vesivirus genus

Virology Journal201815:39

https://doi.org/10.1186/s12985-018-0944-4

Received: 27 November 2017

Accepted: 2 February 2018

Published: 23 February 2018

Abstract

Background

Vesiviruses (family Caliciviridae) had been shown capable of invading a variety of host species, raising concern of their zoonotic potential. Since the 1980’s, several canine caliciviruses (CaCV) isolates have been reported and are phylogenetically related to the vesiviruses with features distinct from both Vesicular exanthema of swine virus (VESV) and Feline calicivirus (FCV) species in phylogeny, serology and cell culture specificities. Etiological studies of canine diseases in dogs used for military services and laboratory studies were conducted in 1963–1978 at the Walter Reed Army Institute of Research. Multiple known and unknown viral pathogens including caliciviruses were recovered.

Methods

Four unidentified isolates were recovered in Walter Reed Canine Cells (WRCC) from respiratory, fecal and penile specimens. Physicochemical tests, electron microscopy, viral cultivation in human and animal cells, antibody neutralization assays, and recently the genome sequencing were used to characterize the isolates. Sera from these dogs and their cohorts were tested with the isolates to determine origin and prevalence of the infections.

Results

The viral isolates were small non-enveloped spherical RNA virions, 27 to 42 nm in diameter with cup-like structures, indicating they are caliciviruses. They propagated in WRCC and MDCK cells, not in either other canine cells or human and other animal cells. Each isolate is antigenically distinct and react with dog sera in respective cohorts. The genomes have nucleotide identities ranging from 70.3% to 90.7% and encode the non-structural polyprotein (1810 amino acids), major capsid protein (691 amino acids) and minor structural protein (134 amino acids). They belong to two different phylogenetic clades in Vesivirus genus with close relation with canine calicivirus (CaCV).

Conclusions

These CaCV isolates have restricted cell tropism, antigenic diversity and genetic variation. Further investigation will shed light on antigenic relation to other vesiviruses, and its pathogenicity for dogs and potential infectivity to other animals. Together with the previously reported CaCV strains provides significant evidence to support the formation of a new CaCV species in the Vesivirus genus.

Keywords

  • Calicivirus
  • Vesivirus
  • Canine calicivirus
  • Viral infection
  • Military dog
  • Animal virus

Background

The caliciviruses (family Caliciviridae) are non-enveloped, positive sense, single-stranded RNA viruses with diameters ranging from 27 to 40 nm. Caliciviruses cause a wide range of significant diseases in human and animals. At present, there are five recognized genera, i.e., Norovirus, Sapovirus, Lagovirus, Vesivirus, and Nebovirus with several additional candidate genera or species proposed and under evaluation by the International Committee on Taxonomy of Viruses (ICTV) [1, 2] (http://www.caliciviridae.com/unclassified/unclassified.htm). In the Vesivirus genus, Vesicular exanthema of swine virus (VESV) and Feline calicivirus (FCV) are two species currently approved by ICTV. Several canine caliciviruses (CaCV) isolates have been identified and shown to be phylogenetically related to vesiviruses with features distinct from both VESV and FCV in phylogeny, serology and cell culture specificities. CaCV is a probable species in the Vesivirus genus, as stated by ICTV [2]. It is still unclassified to date and the evidence presented herein should facilitate the classification and acceptance of CaCV as a species of vesivirus.

Many viruses found in human and other animal species can also infect dogs asymptomatically or cause respiratory, digestive, neurologic and genital diseases with mild to severe symptoms. In response to the use of dogs in military services and laboratory studies, etiological studies of canine diseases were conducted in 1963–1978 at the Walter Reed Army Institute of Research (WRAIR) [3, 4]. In addition to several known canine viral pathogens [5, 6], four unidentified viruses were recovered in Walter Reed Canine Cells (WRCC) producing similar cytopathic effects (CPE). The isolates were not recognized by available human and dog reference virus antisera. Studies of their physicochemical properties and electron microscope observations identified the isolates as likely caliciviruses. Our recent whole genome sequencing of these canine isolates clearly identified them as vesiviruses and elucidated their genetic relationships to the other members of the Caliciviridae family. We herein report the viral isolation and characterization results, which were made in 1963–1978 canine diseases etiological study but were not published, and additional genomics analysis supporting the serological diversity of CaCV strongly suggesting that these isolates and similar CaCV are a unique species within Vesivirus genus [79].

Methods

Collection of the specimens, viral isolations, physicochemical characterization of the viruses and the serological assays were performed in the period of 1963–1978. The purification and genome sequencing of the nucleic acids from the archived viral cultures were done recently.

Specimens

Dog throat, rectal and penile swabs were collected, placed in 2–5 ml of veal infusion broth transport media (Difco Laboratories Inc., Detroit, MI) and frozen at < -60 °C until processed for virus isolation and identification [4]. Blood specimens were collected from each dog and dogs in each cohort at the time and 14–28 days later.

Cell culture and isolation of viruses

The WRCC [6] and primary dog kidney cells (PDK) were prepared in our laboratory; other primary and continuous cells were obtained from commercial sources (Microbiological Associates, Bethesda, Maryland, currently, Lonza, Walkersville, MD). The WRCC were cultured at 35 °C with Medium 199 containing 10% fetal bovine serum, 100 units/ml of penicillin, 100 μg/ml of streptomycin and 2.5 μg/ml of amphotericin B. Cultures for virus studies were maintained in Basal Media Eagle with 2% fetal bovine serum, 1% L-glutamine, and 100 units/ml of penicillin, 100 μg/ml of streptomycin, and 2.5 μg/ml of amphotericin B. Specimens producing cytopathic effects (CPE) were chosen for further study after purification by three terminal dilutions in WRCC. Seed virus preparations were made for virus characterization testing and identification. Virus titrations were done in WRCC.

Determination of isolates’ physicochemical properties

The procedures to determine the presence of a viral envelope by chloroform/ether treatment, type of nucleic acid employing 5-iodo-2-deoxyuridine (IUDR), acid stability (pH 3.0) and heat stability (MgCl2) and size employing membranes of graded porosity are described elsewhere [10].

Prior to negative staining, the virus was partially purified by differential centrifugation at low speed of approximate 10,000×g and high speeds of approximate 100,000×g. The purified virions were stained with 2% phosphotungstic acid and were examined with a Hitachi HU 12 electron microscope. Buoyant density was determined by adding the concentrated virus either by layering or mixing with cesium chloride solution with a refractive index of 1.380 and centrifugation at 33,000 rpm in the SW39 head for 20 h in a Beckman model L ultracentrifuge. After ultracentrifugation, fractions were collected for infectivity and density determinations. For control purposes poliovirus type 1 was tested at the same time and had the expected value of 1.33 g/ml.

Neutralization tests

The neutralization tests were done in WRCC as previously described [4, 11]. Reference antisera for the viral isolates were prepared in rabbits given multiple doses of virus prepared from infected cells maintained in serum-free media. All the pre-immunization sera were free of neutralizing activity to the immunizing virus. Picornavirus and reovirus reference antisera were obtained from the NIH Reference Reagent Program, National Institute of Allergy and Infectious Diseases, Bethesda MD. In addition, antisera to dog viruses were obtained from the Division of Veterinary Medicine, WRAIR.

Nucleic acid extraction and next-generation sequencing

The viral cultures for the isolates made in 1968–1970s and stored at -80 °C were used for purification of viral nucleic acids using the QIAamp viral RNA purification kit (Qiagen Sciences, Germantown, MD). The viral culture supernatant was incubated with nucleases to digest free nucleic acids before lysis and extraction of viruses [12]. The purified nucleic acids were used in random reverse transcription using anchored hexamer oligoes followed by random PCR amplification using the anchored hexamer oligoes and primer for the anchor sequence [13]. The PCR amplicons were subjected to next-generation sequencing (NGS) using MiSeq sequencer and reagents including Nextera XT DNA Library Prep kit and MiSeq Reagent kit v3 (Illumina, San Diego, CA).

Genome sequence assembly and analyses

The sequence data were assembled using Ray de novo genome assembler v2.2 [14] and Roche GS analysis software v2.9 (Roche 454 Life Sciences, Branford, CT, USA). The assembled genome sequences were manipulated and further analyzed using software Geneious version 10.0.9 (Biomatters, Auckland, New Zealand), BLAST programs (http://blast.ncbi.nlm.nih.gov/Blast.cgi), Sequin version 15.50 (https://www.ncbi.nlm.nih.gov/Sequin/) and Molecular Evolutionary Genetics Analysis version 7.0 (MEGA7) [15]. Amino acid sequences were aligned with the MUSCLE program [16] for comparison and phylogenetic analysis. Aligned sequences were used in construction of phylogenetic trees using the maximum-likelihood (ML) method with bootstrap replication of 500 times for calculation of analysis confidence values. The amino acid substitution models for the ML method were compared and the model with the lowest Bayesian Information Criterion (BIC) score was chosen in the analysis [15].

Results

The recovery and physicochemical characterization of the CaCV viruses and the serological study of the CaCV isolates and the dog cohorts were done during etiological studies of canine diseases in 1963–1978. The whole genome sequencing of the nucleic acids from the archived viral cultures were obtained in 2016.

Virus recovery and cohort infections

During 1963 through 1978, four similar CPE producing viral isolates, designated as 3–68, L198 T, A128T and W191R, were recovered from two respiratory, a fecal and a penile specimen respectively from military or laboratory dogs. After initial WRCC inoculation, all isolates produced CPE within two to four days. Each of the isolates was re-isolated and readily propagated in these cells. One dog died shortly after collection. The other three dogs developed neutralizing antibodies to their isolates (Table 1). Neutralizing antibody was detected in 20 to 67% of initial serum specimens from each group of dogs and a small percentage of dogs had a rise in titer (Table 1). In addition to these four isolates, three other viruses were recovered from three of these dogs and identified as canine coronavirus co-infected with L198 T, canine picornavirus with A128T [17] and canine parainfluenza virus with W191R, indicating mixed infections occurred in three surviving dogs.
Table 1

Antibody neutralization assays for the four canine calicivirus isolates

Rabbit antibody

Neutralization titers

Dog Sera A/Pa

Serological prevalence

3–68

W191R

L198 T

A128T

Arrivala

Posta

3–68

>  1024

16

<  4

<  4

< 4 / 32

14/21c

14/21

W191R

<  16

16,384

<  16

<  16

< 4 / 64

6/30

5/30

L198 T

<  4

<  16

256

4

4 / nab

8/29

8/29

A128T

<  4

<  16

<  4

256

< 4 / 16

20/31

21/31d

aA, arrival titers. P, post titers 14–21 days later

bna, not applicable. Post (P) serum not available. Dog died soon after initial specimen collection

cThe number of sera positive in neutralization assay for each CaCV isolate versus the total number tested

dOne additional dog showed an increase in titer to A128T

Chemical and physical characteristics

All four isolates were resistant to chloroform, ether and IUDR treatments, labile at pH 3.0 and were not stabilized at 50 °C in MgCl2. The isolates readily passed through membrane filters with a pore size of 50 nm or larger. The buoyant density in cesium chloride for the 3–68 and L198 T isolates were 1.38 and 1.39 respectively. These findings indicate the isolates are non-enveloped RNA viruses with an estimated diameter of 30 nm. Isolates 3–68, L198 T and W191R were partially purified, negative stained and examined with the electron microscope. The viruses were non-enveloped, 42 nm, 36 nm and 30 nm in diameter respectively, which is similar to the 30 nm diameter of picornaviruses (Table 2). However, the isolated viruses have the cup-like surface structure typical of caliciviruses (Fig. 1) [18]. These characteristics are similar to the caliciviruses, e.g., feline calicivirus (FCV) [19], vesicular exanthema of swine virus (VESV) [20] and Norwalk-like virus (NLV, norovirus) [18].
Table 2

Characteristics of canine calicivirus 3–68 and 48 [28]

 

3–68 (1968)a

48 (1990)a

Membrane Filtration

50 μm passage (< 30 nm)

NDb

EM

30–42 nm

nonenveloped

35–40 nm

nonenveloped

Chloroform/ether

nonenveloped

nonenveloped

Density

1.38 g/ml

1.38 g/ml

IUDR

RNA

RNA

pH 3.0

Acid labile

ND

Heat with MgCl2

Heat labile

ND

Hemagglutination assay

Negative at 4 °C, 25 °C, 37 °C, pH 5, pH 7

Negative at 4 °C, 37 °C

aVirus name and year of specimen collection. Similar findings to the isolate 3–68 were observed for the other three isolates W191R, L198 T and A128T

bND, not determined

Figure 1
Fig. 1

Electron microscopy of negative-stained canine calicivirus isolate W191R. The virus was purified with ultracentrifugation, stained with 2% phosphotungstic acid and examined with a Hitachi HU 12 electron microscope

Antibody neutralization assays

Antibody neutralization assays of the isolates with NIH reference antisera were negative against human poliovirus, echovirus, Coxsackievirus and reoviruses. Assays using antisera to canine viruses including distemper, adenoviruses, herpes, SV5, and canine parvovirus were also negative. The rabbit antisera to each of the isolates were highly specific with 16-fold or higher homologous titers indicating each isolate was antigenically distinct (Table 1). Interestingly, minor non-reciprocal cross reactions occurred between 3 and 68 and W191R and between L198 T and A128T isolates.

Cell culture susceptibility

All four isolates produced CPE in WRCC and MDCK cell cultures. Attempts to propagate the four isolates in other primary and continuous cell lines were unsuccessful. CPEs were not evident in primary dog kidney or thymus cells or A-72 continuous cells from dog or other animal cells including primary human embryo kidney (HEK), human cell line WI-38, primary cells from African green monkey, rhesus monkey kidney, porcine kidney, feline kidney, rabbit kidney, chicken embryo, hamster kidney and the BHK 21 hamster kidney cell line.

Genome sequences and sequence comparison with strains 48 and 2117

Nucleic acid extraction was done with 250 μl of the frozen culture of each isolate and used in viral RNA sequencing. Genome sequences for the isolates were de novo assembled and remapped using MiSeq data. The genomes are close to 8.5 kb in length and contain three open-reading frames encoding putative calicivirus non-structural polyproteins (ORF1), major capsid protein VP1 (ORF2) and small capsid protein VP2 (ORF3) (Additional file 1: Figure S1). There are three nucleotides between ORF 1 and ORF 2, which are GCT for strains 48, isolates A128T and L198 T, and GCA for strains 2117, isolates 3–68 and W191R; consequently ORF 1 and 2 are in the same reading frame. ORF2 and ORF3 overlap by four nucleotides ATGA which shifts the reading frame by + 2, in which ATG and TGA are start and stop codon for ORF3 and ORF2, respectively (Additional file 1: Figure S1). The size and organization of ORFs as well as their putative mature proteins are highly consistent with the two representative CaCV strains, strains 48 (NC_004542.1) [21] and 2117 (AY343325) [7] respectively. Nucleotide identity between genome sequences of strain 48 and 2117 is only 71.3%. Genome sequences of strain 48, A128T and L198 T (designated as type I strain) have identities of 87.6–90.7%. Similarly genome sequences of strain 2117, 3–68 and W191R (designated as type II strain) have 86.5–89.0% identity, while the nucleotide sequence identities between these types I and II strains are only 70.3–72.1%. Pairwise multiple amino acid sequence alignments of the conserved RNA-dependent RNA polymerase (RdRP) show high similarity among these viruses, with amino acid identities of 97.5–97.9% within type I, 97.7–98.6% within type II and 71.5–72.4% between types I and II. In contrast, the amino acid identities for the major capsid protein VP1 are 92.0–95.7% in type I, but only 87.1–89.1% in type II and 69.7–71.0% between types I and II (Table 3).
Table 3

Comparison of amino acid sequences within and between vesiviruses

A.

RdRP

FCV

VESV

SMSV

CaCV

CaCV I

CaCV II

FCV

92.5 ± 1.9

     

VESV

63.4 ± 1.0

93.4 ± 1.6

    

SMSV

59.2 ± 1.0

64.9 ± 1.1

85.5 ± 6.6

   

CaCV

57.5 ± 2.5

64.0 ± 2.3

73.6 ± 3.4

85.2 ± 13.3

  

CaCV I

54.1 ± 0.9

60.9 ± 0.6

69.0 ± 1.5

 

97.4 ± 0.5

 

CaCV II

59.2 ± 0.7

65.6 ± 0.7

75.9 ± 0.7

 

72.0 ± 0.7

98.7 ± 0.5

B.

VP1

FCV

VESV

SMSV

CaCV

CaCV I

CaCV II

FCV

87.4 ± 2.4

     

VESV

46.1 ± 0.8

74.2 ± 6.4

    

SMSV

38.4 ± 1.2

38.7 ± 1.8

66.4 ± 15.5

   

CaCV

37.4 ± 0.8

38.0 ± 1.0

42.3 ± 0.8

78.8 ± 10.5

  

CaCV I

36.7 ± 0.5

39.1 ± 0.5

42.6 ± 0.5

 

92.0 ± 2.9

 

CaCV II

37.7 ± 0.8

37.5 ± 0.8

42.2 ± 0.9

 

67.9 ± 0.9

87.5 ± 3.2

Protein sequences of (A) RNA-dependent RNA polymerase (RdRP) and (B) major capsid protein (VP1) were respectively aligned with MUSCLE program [16]. Data in table are average amino acid identities and standard deviations. GenBank accession numbers of the sequences are shown in Additional file 3: Table S1. FCV, feline calicivirus. VESV, vesicular exanthema. SMSV, San Miguel sea lion virus (SMSV). CaCV, canine calicivirus. CaCV I and II are types I and II of CaCV

Phylogenetic analysis of vesiviruses

There are two established species in genus Vesivirus, FCV and VESV, and additional vesiviruses which are distinct from FCV and VESV and yet to be evaluated. The phylogenetic position of the CaCV isolates were determined based on amino acid sequences of RdRP and VP1 (Fig. 2). Clearly the CaCV isolates A128T and L198 T are close to type I strain 48, while isolates 3–68 and W191R are close to type II strain 2117. These results showed that these CaCVs phylogenetically belong to genus vesivirus with clear separation from species FCV and VESV. The known CaCV strains and isolates possibly form two phylogenetic clades. Sequence divergences of CaCV from species FCV or VESV for both RdRP and VP1 proteins are closer to or larger than the distance between FCV and VESV (Table 3). Small genetic variations are seen among viruses within FCV and VESV species, with high amino acid identities of 92.5 ± 1.9% and 93.4 ± 1.6% for RdRP respectively. In contrast, CaCV viruses and San Miguel sea lion viruses (SMSV), despite the small number of identified isolates for each virus, are much more genetically diverse, with RdRP amino acid identities of 85.5 ± 6.6% and 85.2 ± 13.3% respectively. It is interesting that SMSV shared remarkable sequence identities with CaCV, having RdRP amino acid identities of 69.0 ± 1.5% with type I viruses and 75.9 ± 0.7% with type II viruses respectively, comparable to the identity of 72.0 ± 0.7% between types I and II viruses. However, the VP1 sequences differ greatly between SMSV and CaCV, with identity of only 42.2 ± 0.9%, compared to the 65.7% ± 3.4% identity between types I and II viruses. This difference is comparable to the level of difference in VP1 proteins between species FCV and VESV.
Figure 2
Fig. 2

Phylogenetic analysis of canine caliciviruses and related vesiviruses based on complete amino acid sequences of a RNA-dependent RNA polymerase (RdRP) and b major capsid protein VP1. The selected protein sequences were aligned with the MUSCLE program and used in phylogenetic analyses by the Maximum Likelihood method based on the Le_Gascuel_2008 model. The scale bar represents the number of amino acid substitutions per site. FCV, feline calicivirus. SSLV, Steller sea lion vesivirus. SMSV, San Miguel sea lion virus. MCV, mink calicivirus. FBCV, ferret badger vesivirus

Major capsid protein sequences

ORF2 encodes the major capsid protein precursor of about 690 amino acids. Alignment of amino acid sequences of four CaCV isolates and strains 48 and 2117 (Additional file 2: Figure S2) reveals the existence of conserved motifs, e.g. FRAES (capsid cleavage site), PPG, and the 7-amino-acid CaCV-specific insertion (N/S/K)(S/A/T)IKS(D/S/Q)(I/V) [7, 8] and the existence of multiple potential hyper-variable regions (HVR) at amino acid positions (number for strain 48 VP1) 379−403 (HVR1), 420−458 (HVR2), 467−525 (HVR3), 543−560 (HVR4), and 586−602 (HVR5) (Additional file 2: Figure S2). The antigenically highly distinguishable (Table 1) but genetically highly similar pairs of isolates (Table 3), A128T/L198 T and W191R/3–68 differ by 50 and 89 amino acid residues respectively. Most differences are located in the hyper-variable regions in which the amino acids differ between and within the each pair.

Discussion

Previous studies of caliciviruses in dogs have reported the recovery of feline calicivirus [22], norovirus [2325] and sapovirus [26, 27] as well as the candidate canine calicivirus 48 [28] and Bari/212/07/ITA [8]. With the exception of the murine noroviruses, only the vesiviruses can be readily grown in cell culture. This report describes the isolation and identification of four additional canine calicivirus isolates and their molecular characterization. Each of these canine isolates was made solely in the canine WRCC and their canine origin is supported by neutralizing antibody studies in both the dogs providing the isolates and their cohorts (Table 1). The initial physical and chemical studies and electron microscopic observations clearly indicate the isolates are caliciviruses. These characteristics are highly consistent with the few reports since 1985 that establish canine calicivirus as a new virus belonging to the vesivirus genus but distinct from FCV and VESV species [2831].

Neither FCV virus nor antisera for FCV were available to us at the time to examine the serological relationship of these isolates with FCV. Each of the four isolates was antigenically distinct in neutralization tests with only two minor non-reciprocal cross reactions (Table 1).

Determination of each isolate’s genome sequence clearly identified each isolate as a member of the vesivirus genus in the Caliciviridae family and phylogenetically separate from FCV and VESV species. CaCV apparently has two serologically distinct and genetically divergent types: type I which includes strains 48, isolates A128T and L198 T; and type II which includes strain Bari/212/07/ITA, isolates 3–68 and W191R as well as 2117 and several 2117-like vesiviruses. It is remarkable that CaCV type II viruses share very high amino acid identities for RdRP (98.7% ± 0.5%), but substantially lower identities (87.5 ± 3.2) for VP1. It is rational to speculate that the high divergence of VP1 associates with capsid structure variation, antigenic diversity and in consequence broadened host specificity. It has been shown that vesivirus 2117 has a capsid structure more similar to sapovirus and lagovirus than to vesiviruses and potentially alterations in receptor binding [32]. Vesivirus 2117 [7] and 2117-like viruses Allston 2008/US (GenBank accession GQ475302), Allston 2009/US (GQ475301) and Geel 2008/Belgium (GQ475301) were identified as viral contaminants causative of CPE in production line Chinese hamster ovary (CHO) cells. The origin of these viruses is unknown but possibly from dogs [33]. Vesivirus 2117 can readily grow and develop CPE in MDCK and CHO-K1 cells. CPE in BHK-21 is weak in the first passage and more obvious in the second passage [34]. In a previous study the virus propagated in CHO cells but not in other cells including MDCK and BHK [7]. In our study, isolates 3–68 and W191R were isolated from dogs and maintained in the WRCC dog cell line. Neither produced visible CPE in BHK-21 cultures in first passage. Isolates 3–68 and W191R have respective amino acid identities of 88.7% and 85.7% for VP1 with strain 2117. The divergence of capsid sequences may have contributed to the adaptation of strain 2117 to hamster cells. It is important that the strain 2117-like viruses from CHO cells at three different locations, i.e. Germany, USA and Belgium are significantly different from each other by 14.1 ± 0.9% for VP1 proteins, a similar extent as the distances with other CaCV II viruses. The large heterogeneity of major capsid proteins of CaCV and the evidence of possible cross species infectivity indicates the potential zoonotic transmission of CaCV. Speculation of possible canine to human transmission is supported by the recent finding of Bari/212/07/ITA antibodies in 7.8% of human sera tested in Italy [35].

The serological and molecular assays of CaCV in dogs evidently show a high prevalence of CaCV infection in dogs [33, 36, 37]. In our study, for each isolate we saw rising antibody titers in convalescent sera in comparison with acute sera from each of the three surviving dogs. CaCV antibodies against each isolate were found in acute sera from other dogs in each cohort and only one other dog with rising antibody titer (Table 1). The data clearly suggest the infections by CaCV occurred after the dogs arrived in their cohorts.

Interestingly, the very weak serological cross reactions between the pairs A128T/L198 T and W191R/3–68 can be precisely correlated with the close phylogenetic proximity of each pair. More importantly, the major capsid (VP1) proteins for each pair differ by only a small number of residues, most of which are within HVRs. Further study on these residues may delineate the key antigenic sites responsible for receptor-binding or immunity.

Further genome analyses of the four canine isolates and the previously reported canine 48, Bari/212/07/ITA and Vesivirus 2112 viruses show them forming two clades or species, the first comprising the 48 canine virus with the A128T and L128 T isolates and the second comprising the 2117 and Bari/212/07/ITA canine viruses with the canine 3–68 and W191R isolates (Fig. 2). Examination of the capsid genome of the four isolates and the 48 and 2117 strains reveals HVRs, i.e. nt429 to nt444 which may also be related to the antigenic differences among the newly reported genomes and possibly of significance in the development of specific neutralizing antibodies.

Conclusions

The physicochemical, serological and molecular study of the four WRAIR canine calicivirus isolates from the late 1960’s and 1970’s have identified the isolates as candidate members of the Vesivirus genus of Caliciviridae. The detailed analyses demonstrated the restricted cell tropism, antigenic diversity and genetic variation of the CaCV viruses. The genomes of the four isolates together with the previously reported canine 48 and Bari/212/07/ITA strains provide significant additional evidence to support the formation in the canine vesivirus genus of canine calicivirus (CaCV) species consisting of at least two clades/types. Identification of the antigenically distinct vesiviruses capable of growth in cell culture provides a valuable model for studying the role of specific neutralizing antibody in protection against infection and disease during calicivirus infections.

Abbreviations

CaCV: 

Canine caliciviruses

CPE: 

Cytopathic effects

FBCV: 

Ferret badger vesivirus

FCV: 

Feline calicivirus

HVR: 

Hyper-variable region

ICTV: 

The International Committee on Taxonomy of Viruses

IUDR: 

5-iodo-2-deoxyuridine

MCV: 

Mink calicivirus

NGS: 

Next-generation sequencing

PDK: 

Dog kidney cells

RdRP: 

RNA-dependent RNA polymerase

SMSV: 

San Miguel sea lion virus

SSLV: 

Steller sea lion vesivirus

VESV: 

Vesicular exanthema of swine virus

WRCC: 

Walter Reed Canine Cells

Declarations

Acknowledgments

The authors thank Mr. Walter Engler of the Armed Forces Institute of Pathology for his highly skillful contributions of the negative staining and determinations of the buoyant density of the canine calicivirus isolates to this study.

Disclaimers

The views expressed here are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense or U.S. Government. This is the work of U.S. government employees and may not be copyrighted (17 USC 105).

Funding

This work is supported by the Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center.

Availability of data and materials

Genome sequences of the four canine calicivirus isolates from this study were deposited in GenBank under accession numbers MF327134– MF327137.

Authors’ contributions

LNB and JH designed the study. LNB and RHM conducted the viral isolation and characterization experiments. EAN purified nucleic acids and performed next-gen sequencing. LNB and JH analyzed the data. RGJ and PBK contributed the reagents/materials/analysis tools. JH and LNB wrote the manuscript. All authors read, revised, and approved the final manuscript.

Ethics approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, USA

References

  1. Lefkowitz E, Adams MJ, Davison AJ, Siddell SG, and Simmonds P. (eds). Virus Taxonomy: Classification and Nomenclature of Viruses: Online Report of the International Committee on Taxonomy of Viruses. https://talk.ictvonline.org/ictv-reports/ictv_online_report/.
  2. Clarke I, Estes MK, Green KY, Hansman GS, Knowles NJ, Koopmans MK, Matson DO, Meyers G, Nill JD, Radford A, Smith AW, Studdert MJ, Thiel HJ, Vinjé JC. In: AMQ K, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Virus taxonomy: classification and nomenclature of viruses: ninth report of the international committee on taxonomy of viruses. San Diego: Elsevier; 2012. p. 977–86.Google Scholar
  3. Binn LN, Lazar EC, Helms J, Viral CRE. Antibody patterns in laboratory dogs with respiratory disease. Am J Vet Res. 1970;31:697–702.PubMedGoogle Scholar
  4. Binn LNA. Review of viruses recovered from dogs. J Am Vet Med Assoc. 1970;156:1672–7.PubMedGoogle Scholar
  5. Binn LN, Comments LEC. On epizootiology of parainfluenza SV-5 in dogs. J Am Vet Med Assoc. 1970;156:1774–7.PubMedGoogle Scholar
  6. Binn LN, Lazar EC, Eddy GA, Kajima M. Recovery and Characterization of a minute virus of canines. Infect Immun. 1970;1:503–8.PubMedPubMed CentralGoogle Scholar
  7. Oehmig A, Buttner M, Weiland F, Werz W, Bergemann K, Pfaff E. Identification of a calicivirus isolate of unknown origin. J Gen Virol. 2003;84:2837–45.View ArticlePubMedGoogle Scholar
  8. Martella V, Pinto P, Lorusso E, Di Martino B, Wang Q, Larocca V, Cavalli A, Camero M, Decaro N, Banyai K, Saif LJ, Buonavoglia C. Detection and full-length genome characterization of novel canine Vesiviruses. Emerg Infect Dis. 2015;21:1433–6.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Matsuura Y, Tohya Y, Nakamura K, Shimojima M, Roerink F, Mochizuki M, Takase K, Akashi H, Complete ST. Nucleotide sequence, genome organization and phylogenic analysis of the canine calicivirus. Virus Genes. 2002;25:67–73.View ArticlePubMedGoogle Scholar
  10. Spertzel RO, Huxsoll DL, McConnell SJ, Binn LN, Yager RH. Recovery and characterization of a herpes-like virus from dog kidney cell cultures. Proc Soc Exp Biol Med. 1965;120:651–5.View ArticlePubMedGoogle Scholar
  11. Binn LN, Koughan WP, Lazar EA. Simple plaque procedure for comparing antigenic relationships of canine herpesvirus. J Am Vet Med Assoc. 1970;156:1724–5.PubMedGoogle Scholar
  12. Hang J, Vento TJ, Norby EA, Jarman RG, Keiser PB, Kuschner RA, Binn LN. Adenovirus type 4 respiratory infections with a concurrent outbreak of coxsackievirus A21 among United States Army basic trainees, a retrospective viral etiology study using next-generation sequencing. J Med Virol. 2017;89:1387–94.View ArticlePubMedGoogle Scholar
  13. Hang J, Forshey BM, Kochel TJ, Li T, Solorzano VF, Halsey ES, Kuschner RA. Random amplification and pyrosequencing for identification of novel viral genome sequences. J Biomol Tech. 2012;23:4–10.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Boisvert S, Laviolette F, Corbeil J. Ray: simultaneous assembly of reads from a mix of high-throughput sequencing technologies. J Comput Biol. 2010;17:1519–33.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.View ArticlePubMedGoogle Scholar
  16. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Norby EE, Jarman RG, Keiser PB, Binn LN, Hang J. Genome sequence of a novel canine picornavirus isolated from an American foxhound. Genome Announc. 2017;5:e00338-17.Google Scholar
  18. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Visualization CRM. By immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol. 1972;10:1075–81.PubMedPubMed CentralGoogle Scholar
  19. Peterson JE, Studdert MJ. Feline picornavirus. Structure of the virus and electron microscopic observations on infected cell cultures. Arch Gesamte Virusforsch. 1970;32:249–60.View ArticlePubMedGoogle Scholar
  20. Zee YC, Hackett AJ, Electron TLT. Microscopic studies on the vesicular exanthema of swine virus. II. Morphogenesis of VESV type H54 in pig kidney cells. Virology. 1968;34:596–607.View ArticlePubMedGoogle Scholar
  21. Roerink F, Hashimoto M, Tohya Y, Mochizuki M. Genetic analysis of a canine calicivirus: evidence for a new clade of animal caliciviruses. Vet Microbiol. 1999;69:69–72.View ArticlePubMedGoogle Scholar
  22. Martella V, Pratelli A, Gentile M, Buonavoglia D, Decaro N, Fiorente P, Buonavoglia C. Analysis of the capsid protein gene of a feline-like calicivirus isolated from a dog. Vet Microbiol. 2002;85:315–22.View ArticlePubMedGoogle Scholar
  23. Mesquita JR, Nascimento MS. Gastroenteritis outbreak associated with faecal shedding of canine norovirus in a Portuguese kennel following introduction of imported dogs from Russia. Transbound Emerg Dis. 2012;59:456–9.View ArticlePubMedGoogle Scholar
  24. Ntafis V, Xylouri E, Radogna A, Buonavoglia C, Martella V. Outbreak of canine norovirus infection in young dogs. J Clin Microbiol. 2010;48:2605–8.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Scipioni A, Mauroy A, Vinje J, Thiry E. Animal noroviruses. Vet J. 2008;178:32–45.View ArticlePubMedGoogle Scholar
  26. Gabriel SS, Tohya Y, Mochizuki M. Isolation of a calicivirus antigenically related to feline caliciviruses from feces of a dog with diarrhea. J Vet Med Sci. 1996;58:1041–3.View ArticlePubMedGoogle Scholar
  27. Soma T, Nakagomi O, Nakagomi T, Mochizuki M. Detection of norovirus and Sapovirus from diarrheic dogs and cats in Japan. Microbiol Immunol. 2015;59:123–8.View ArticlePubMedGoogle Scholar
  28. Mochizuki M, Kawanishi A, Sakamoto H, Tashiro S, Fujimoto R, Ohwaki M. A calicivirus isolated from a dog with fatal diarrhoea. The Veterinary record. 1993;132:221–2.View ArticlePubMedGoogle Scholar
  29. Crandell RA. Isolation and characterization of caliciviruses from dogs with vesicular genital disease. Arch Virol. 1988;98:65–71.View ArticlePubMedGoogle Scholar
  30. Schaffer FL, Soergel ME, Black JW, Skilling DE, Smith AW, Cubitt WD. Characterization of a new calicivirus isolated from feces of a dog. Arch Virol. 1985;84:181–95.View ArticlePubMedGoogle Scholar
  31. Evermann JF, McKeirnan AJ, Smith AW, Skilling DE, Ott RL. Isolation and identification of caliciviruses from dogs with enteric infections. Am J Vet Res. 1985;46:218–20.PubMedGoogle Scholar
  32. Conley M, Emmott E, Orton R, Taylor D, Carneiro DG, Murata K, Goodfellow IG, Hansman GS, Bhella D. Vesivirus 2117 capsids more closely resemble sapovirus and lagovirus particles than other known vesivirus structures. J Gen Virol. 2017;98:68–76.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Di Martino B, Di Profio F, Bodnar L, Melegari I, Sarchese V, Massirio I, Dowgier G, Lanave G, Marsilio F, Banyai K, Buonavoglia C, Martella V. Seroprevalence for 2117-like vesiviruses in Italian household dogs. Vet Microbiol. 2017;201:14–7.View ArticlePubMedGoogle Scholar
  34. Plavsic M, Shick K, Bergmann KF, Mallet L. Vesivirus 2117: cell line infectivity range and effectiveness of amplification of a potential adventitious agent in cell culture used for biological production. Biologicals. 2016;44:540–5.View ArticlePubMedGoogle Scholar
  35. Di Martino B, Di Profio F, Lanave G, De Grazia S, Giammanco GM, Lavazza A, Buonavoglia C, Marsilio F, Banyai K, Martella V. Antibodies for strain 2117-like vesiviruses (caliciviruses) in humans. Virus Res. 2015;210:279–82.View ArticlePubMedGoogle Scholar
  36. Jang HK, Tohya Y, Han KY, Kim TJ, Song CS, Mochizuki M. Seroprevalence of canine calicivirus and canine minute virus in the Republic of Korea. Vet Rec. 2003;153:150–2.View ArticlePubMedGoogle Scholar
  37. Mochizuki M, Hashimoto M, Roerink F, Tohya Y, Matsuura Y, Sasaki N. Molecular and seroepidemiological evidence of canine calicivirus infections in Japan. J Clin Microbiol. 2002;40:2629–31.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement